Latest / Decera Clinical Education Oncology Podcast
Advancing KRAS G12C-Targeted Therapies in NSCLC: Current Evidence and Future Directions
In this episode, Dr Paz-Ares and Dr Christine Bestvina discuss the evolving role of KRAS G12C inhibitors in non-small-cell lung cancer (NSCLC), including:
Clinical outcomes and limitations of first-generation KRAS G12C inhibitors
Key unmet needs, including primary and acquired resistance
Emerging strategies, including next-generation inhibitors and combination approaches with chemotherapy and immunotherapy
Presenters:
Luis Paz-Ares, MD, PhD
Head of Medical Oncology Department
Hospital Universitario 12 de Octubre
Associate Professor, Universidad Complutense de Madrid
Madrid, Spain
Christine…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.